ScienceOpen and Future Science Group have announced an extended collaboration that integrates two new featured collections covering the latest scientific findings in drug discovery and biotechniques into the ScienceOpen research discovery environment. These collections join the already featured open-access article collection ‘Future Science: Open Access’ that includes research, review and opinion articles from across the biomedical sciences.
ScienceOpen’s partnership with Future Science Group marks an important contribution to advancing clinical practice and drug research. Future Science Group’s portfolio consists of three publishing imprints, Future Science, Future Medicine, Newlands Press, as well as a content development imprint, PharmaPlatforms. ScienceOpen’s freely accessible and interactive discovery environment of over 55 million article records places Future Science Group’s journal content within a broader research framework.
Future Science Group’s new collections on ScienceOpen feature two journals - Future Drug Discovery and BioTechniques.
Future Science Group aims to advance clinical practice and drug research by optimising the communication between clinicians, researchers and decision-makers, and by providing innovative solutions to that end. ScienceOpen’s interactive features such as community curation, article reviews, comments and recommendations benefit all stakeholders by facilitating public engagement with scholarly research and increasing research discoverability.
ScienceOpen and Future Science Group believe that integrating ‘Future Drug Discovery’ and ‘BioTechniques’ will increase the global impact of latest scientific discoveries in these fields.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
